Early coagulation disorders after severe burn injury: Impact on mortality

Intensive Care Medicine

Volumn 34, Issue 4, 2008, Pages 700-706

  Lavrentieva, Athina ^a,b   Kontakiotis, Theodore ^c   Bitzani, Militsa ^b   Papaioannou Gaki, Georgia ^d   Parlapani, Angeliki ^c   Thomareis, Olimpia ^c   Tsotsolis, Nicolaos ^c   Giala, Maria Amalia ^c  

^a Burn ICU Papanikolaou General Hospital ^*  (Greece)

^b G PAPANICOLAOU HOSPITAL   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

Author keywords

Burn; Coagulation factors; Disseminated intravascular coagulation; Outcome assessment

Indexed keywords

ANTITHROMBIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; PROTEIN S; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; BURN; BURN PATIENT; CLINICAL ARTICLE; DISEASE COURSE; DISEASE MARKER; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FIBRINOLYSIS; HUMAN; INTENSIVE CARE UNIT; MALE; MULTIPLE ORGAN FAILURE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; ROC CURVE; SCORING SYSTEM; SURVIVOR; TERTIARY HEALTH CARE;

ADULT; BIOLOGICAL MARKERS; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; BURNS; DISSEMINATED INTRAVASCULAR COAGULATION; EARLY DIAGNOSIS; FEMALE; GREECE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE; SURVIVAL RATE;

EID: 43349086815     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-007-0976-5     Document Type: Article

References (28)

1. Shankar R, Amin C, Gamelli RL (2002) Hematologic, hematopoetic, and acute phase response. In: Herndon D (ed) Total burn care, 2nd edn. Saunders, Harcourt New York, pp 331-346
2. Opal SM (2000) Phylogenetic and functional relationships between coagulation and the innate immune response. Crit Care Med 28:S77-S80
3. Heideman M (1979) The effect of thermal injury on hemodynamic, respiratory, and hematologic variables in relation to complement activation. J Trauma 19:239-247
4. Souter PJ, Thomas S, Hubbard AR, Poole S, Romisch J, Gray E (2001) Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood. Crit Care Med 29:134-139
5. Bartlett RH, Fong SV, Maruggo G, Hardeman T, Anderson V (1981) Coagulation and platelets changes after thermal injury in man. Burns 7:370-377
6. Wells S, Sissons M, Hasleton PS (1984) Quantitation of pulmonary megakaryocytes and fibrin thrombi in patients dying from burns. Histopathology 8:517-527
7. Kowal-Vern A, Gamelli RL, Walenga JM, Hoppensteadt D, Sharp-Pucci M, Schumacher HR (1992) The effect of burn wound size on hemostasis: a correlation of the hemostatic changes to the clinical state. J Trauma 33:50-56
8. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M (2001) Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86:1327-1330
9. Bakhtiari K, Meijers JC, de Jonge E, Levi M (2004) Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 32:2416-2421
10. Gando S, Iba T, Eguchi Y, Ohtomo Y, Okamoto K, Koseki K, Mayumi T, Murata A, Ikeda T, Ishikura H, Ueyama M, Ogura H, Kushimoto S, Saitoh D, Endo S, Shimazaki S, Japanese Association for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) Study Group (2006) A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med 34:625-631
11. Kienast J, Juers M, Wiedermann CJ, Hoffmann JN, Ostermann H, Strauss R, Keinecke HO, Warren BL, Opal SM, KyberSept investigators (2006) Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost 4:90-97
12. Sivula M, Tallgren M, Pettila V (2005) Modified score for disseminated intravascular coagulation in the critically ill. Intensive Care Med 31:1209-1214
13. Garcia-Avello A, Lorente JA, Cesar-Perez J, Garcia-Frade LJ, Alvarado R, Arevalo JM, Navarro JL, Esteban A (1998) Degree of hypercoagulability and hyperfibrinolysis is related to organ failure and prognosis after burn trauma. Thromb Res 89:59-64
14. Levi M (2005) Disseminated intravascular coagulation: what's new? Crit Care Clin 21:449-467
15. Kollef MH, Eisenberg PR, Shannon W (1998) A rapid assay for the detection of circulating D-dimer is associated with clinical outcomes among critically ill patients. Crit Care Med 26:1054-1060
16. Gando S, Nanzaki S, Sasaki S, Aoi K, Kemmotsu O (1998) Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock. Crit Care Med 26:2005-2009
17. Moreno R, Vincent JL, Matos R, Mendonca A, Cantraine F, Thijs L, Takala J, Sprung C, Antonelli M, Bruining H, Willatts S (1999) The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM. Intensive Care Med 25:686-696
18. Dhainaut JF, Yan SB, Joyce DE, Pettila V, Basson B, Brandt JT, Sundin DP, Levi M (2004) Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost 2:1924-1933
19. Mavrommatis AC, Theodoridis T, Economou M, Kotanidou A, El Ali M, Christopoulou-Kokkinou V, Zakynthinos SG (2001) Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock. Intensive Care Med 27:1853-1859
20. Barret JP, Gomez PA (2005) Disseminated intravascular coagulation: a rare entity in burn injury. Burns 31:354-357
21. Aoki K, Aikawa N, Sekine K, Yamazaki M, Mimura T, Urano T, Takada A (2001) Elevation of plasma free PAI-1 levels as an integrated endothelial response to severe burns. Burns 27:569-575
22. Kowal-Vern A, McGill V, Walenga JM, Gamelli RL (2000) Antithrombin (H) concentrate infusions are safe and effective in patients with thermal injuries. J Burn Care Rehabil 21:115-127
23. Hesselvik JF, Blomback M, Brodin B, Maller R (1989) Coagulation, fibrinolysis, and kallikrein systems in sepsis: relation to outcome. Crit Care Med 17:724-733
24. Lorente JA, Garcia-Frade LJ, Landin L, de Pablo R, Torrado C, Renes E, Garcia-Avello A (1993) Time course of hemostatic abnormalities in sepsis and its relation to outcome. Chest 103:1536-1542
25. Aoki K, Nishino N, Baba S, Urano T, Takada A (1994) Postoperative changes in plasma tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. Surg Today 24:1039-1043
26. Watanabe R, Wada H, Watanabe Y, Sakakura M, Nakasaki T, Mori Y, Nishikawa M, Gabazza EC, Nobori T, Shiku H (2001) Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation. Thromb Res 104:1-6
27. Soejima K, Schmalstieg FC, Sakurai H, Traber LD, Traber DL (2001) Pathophysiological analysis of combined burn and smoke inhalation injuries in sheep. Am J Physiol Lung Cell Mol Physiol 280:L1233-L1241
28. Murakami K, McGuire R, Cox RA, Jodoin JM, Schmalstieg FC, Traber LD, Hawkins HK, Herndon DN, Traber DL (2003) Recombinant antithrombin attenuates pulmonary inflammation following smoke inhalation and pneumonia in sheep. Crit Care Med 31:577-583